bio-cold-chain-995x60 bio-cold-chain-995x60

FEATURED ARTICLES

  • The Direct-To-Patient Model: Your Top 10 Q&A

    In clinical trials, a direct-to-patient model allows for drug therapies to be delivered and administered in the patient’s home and/or biological samples to be taken and uplifted from the patient’s home. Depending on the complexity of the trial protocols, patients may take medicines themselves, or rely on a homecare nurse or caregiver for clinical support. Because the direct-to-patient model allows the patient to participate in the clinical trial from home, it reduces the need for them to travel to the investigator site, increasing the likelihood they will agree to participate and decreasing the possibility that they will drop out of the study.

More Featured Articles

WHITE PAPERS & CASE STUDIES

  • Clinical Trial Logistics In Africa: Ensuring Quality, Compliance And Control

    Today’s Africa has increasingly become a source of fascination for pharmaceutical researchers drawn to the study and control of both communicable diseases such as malaria, tuberculosis and HIV/AIDS as well as diseases of the developed world like cancer, diabetes, hypertension and chronic respiratory disease. By World Courier

More White Papers & Case Studies

PRODUCTS & SERVICES

Clinical Trial Cold Chain Logistics Clinical Trial Cold Chain Logistics

World Courier is the largest, most successful specialty courier company in the world. Each dot represents one of over 140 company owned offices, nearly ten times the number of offices of all other specialty courier services combined!

More Products & Services